Pulse Biosciences posts updated investor deck highlighting CellFX nsPFA device progress

PULSE BIOSCIENCES, INC.

Updated deck discloses progress on CellFX nsPFA 360 Cardiac Catheter development.
Progress also detailed for CellFX nsPFA Cardiac Clamp and Percutaneous Electrode.
Presentation dated January 2025; posted on company website under Investors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.